M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.081 AUD 1.25% Market Closed
Market Cap: AU$49.3m

Microba Life Sciences Ltd
Total Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Microba Life Sciences Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
Microba Life Sciences Ltd
ASX:MAP
Total Receivables
AU$4.1m
CAGR 3-Years
6%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Sonic Healthcare Ltd
ASX:SHL
Total Receivables
AU$1.6B
CAGR 3-Years
17%
CAGR 5-Years
5%
CAGR 10-Years
9%
Integral Diagnostics Ltd
ASX:IDX
Total Receivables
AU$28.5m
CAGR 3-Years
7%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Australian Clinical Labs Ltd
ASX:ACL
Total Receivables
AU$72.8m
CAGR 3-Years
-7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Apiam Animal Health Ltd
ASX:AHX
Total Receivables
AU$12.9m
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
N/A
H
Healius Ltd
ASX:HLS
Total Receivables
AU$170m
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
0%
No Stocks Found

Microba Life Sciences Ltd
Glance View

Market Cap
49.3m AUD
Industry
Health Care

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.

MAP Intrinsic Value
0.126 AUD
Undervaluation 36%
Intrinsic Value
Price
M

See Also

What is Microba Life Sciences Ltd's Total Receivables?
Total Receivables
4.1m AUD

Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Total Receivables amounts to 4.1m AUD.

What is Microba Life Sciences Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
46%

Over the last year, the Total Receivables growth was -49%. The average annual Total Receivables growth rates for Microba Life Sciences Ltd have been 6% over the past three years , 46% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett